Stay updated on GEMINI 1 Tolebrutinib Clinical Trial

Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has removed the estimated timestamps for when results were first posted and last updated, which may affect users' understanding of the timeliness of the information provided.
    Difference
    0.0%
    Check dated 2025-06-27T00:30:49.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest expected in July 2025, with significant details about trial parameters, including treatment durations and assessment metrics for multiple sclerosis. Additionally, the expected study duration has been clarified to approximately 48 months, and specific treatment regimens have been detailed.
    Difference
    47%
    Check dated 2025-06-19T19:30:03.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has been updated to reflect that results have now been submitted, and the revision number has changed from v2.16.1 to v2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:06:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.9%
    Check dated 2025-05-29T05:54:04.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:59:00.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page has been updated to include new information about relapsing multiple sclerosis and a new registry identifier, while significant details regarding the study's objectives, duration, and inclusion/exclusion criteria have been removed.
    Difference
    23%
    Check dated 2025-04-16T05:24:40.000Z thumbnail image

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.